, Tracking Stock Market Picks
Enter Symbol:

up 245.11 %

SUCAMPO PHARMACEUTICALS INC (SCMP) rated Buy with price target $29 by ROTH Capital

Posted on: Thursday,  Oct 29, 2015  9:25 AM ET by Roth Capital

Roth Capital rated Buy SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP) on 10/29/2015. Previously Roth Capital rated Buy SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP) on
10/22/2014., when the stock price was $8.09. Since then, SUCAMPO PHARMACEUTICALS INC has gained 245.12% as of 01/22/2016's recent price of $27.92.
If you would have followed the previous Roth Capital's recommendation on SCMP, you would have gained 245.11% of your investment in 457 days.

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones for the treatment of gastrointestinal, respiratory, vascular and central nervous system diseases and disorders.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2015 9:25 AM Buy
20.41 29.00
as of 8/27/2015
1 Week up  12.71 %
1 Month up  63.17 %
3 Months up  75.04 %
1 YTD up  94.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/20/2015 9:25 AM Buy
14.33 20.00
10/22/2014 8:25 AM Buy
8.09 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy